![Exon Junction Complexes Show a Distributional Bias toward Alternatively Spliced mRNAs and against mRNAs Coding for Ribosomal Proteins - ScienceDirect Exon Junction Complexes Show a Distributional Bias toward Alternatively Spliced mRNAs and against mRNAs Coding for Ribosomal Proteins - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124716308658-fx1.jpg)
Exon Junction Complexes Show a Distributional Bias toward Alternatively Spliced mRNAs and against mRNAs Coding for Ribosomal Proteins - ScienceDirect
![Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice | Nature Medicine Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnm.3628/MediaObjects/41591_2014_Article_BFnm3628_Fig1_HTML.jpg)
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice | Nature Medicine
![The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output | Science Advances The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf7561/asset/961dc8db-1aa2-427a-bc64-d1bc13ef9749/assets/images/large/sciadv.abf7561-f1.jpg)
The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output | Science Advances
Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy
![CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells | Science Advances CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells | Science Advances](https://www.science.org/cms/10.1126/sciadv.aav4324/asset/32dfc3fc-6023-4d5b-87cb-c056201396f5/assets/graphic/aav4324-f1.jpeg)
CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells | Science Advances
![Exon 46 skipping in cultured mouse C2C12 muscle cells. (A) Gel mobility... | Download Scientific Diagram Exon 46 skipping in cultured mouse C2C12 muscle cells. (A) Gel mobility... | Download Scientific Diagram](https://www.researchgate.net/publication/31222727/figure/fig2/AS:340382828253185@1458164998087/Exon-46-skipping-in-cultured-mouse-C2C12-muscle-cells-A-Gel-mobility-shift-assay.png)
Exon 46 skipping in cultured mouse C2C12 muscle cells. (A) Gel mobility... | Download Scientific Diagram
![PDF] The Crystal Structure of the Exon Junction Complex Reveals How It Maintains a Stable Grip on mRNA | Semantic Scholar PDF] The Crystal Structure of the Exon Junction Complex Reveals How It Maintains a Stable Grip on mRNA | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2b14f4216de630acffe0a1bd2976204b5af5e657/6-Figure2-1.png)
PDF] The Crystal Structure of the Exon Junction Complex Reveals How It Maintains a Stable Grip on mRNA | Semantic Scholar
![Long-Term Efficacy of Systemic Multiexon Skipping Targeting Dystrophin Exons 45–55 With a Cocktail of Vivo-Morpholinos in Mdx52 Mice: Molecular Therapy - Nucleic Acids Long-Term Efficacy of Systemic Multiexon Skipping Targeting Dystrophin Exons 45–55 With a Cocktail of Vivo-Morpholinos in Mdx52 Mice: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/2076140623/2070098492/gr1.jpg)
Long-Term Efficacy of Systemic Multiexon Skipping Targeting Dystrophin Exons 45–55 With a Cocktail of Vivo-Morpholinos in Mdx52 Mice: Molecular Therapy - Nucleic Acids
![Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy | PNAS Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy | PNAS](https://www.pnas.org/cms/asset/02183650-3859-49a2-90ee-93218f1ab182/keyimage.jpg)
Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy | PNAS
![Exon Junction Complex Subunits Are Required to Splice Drosophila MAP Kinase, a Large Heterochromatic Gene: Cell Exon Junction Complex Subunits Are Required to Splice Drosophila MAP Kinase, a Large Heterochromatic Gene: Cell](https://www.cell.com/cms/attachment/2056496552/2061395229/fx1.jpg)